Growth Metrics

SOPHiA GENETICS (SOPH) Cash from Financing Activities (2020 - 2025)

SOPHiA GENETICS's Cash from Financing Activities history spans 6 years, with the latest figure at -$385000.0 for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 67.04% to -$385000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $30.2 million, a 206.15% increase, with the full-year FY2025 number at $30.2 million, up 206.15% from a year prior.
  • Cash from Financing Activities hit -$385000.0 in Q4 2025 for SOPHiA GENETICS, up from -$2.0 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for SOPH hit a ceiling of $237.7 million in Q3 2021 and a floor of -$2.0 million in Q3 2025.
  • Historically, Cash from Financing Activities has averaged $13.7 million across 5 years, with a median of -$599500.0 in 2022.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 366.81% in 2023 and later skyrocketed 2187.56% in 2024.
  • Tracing SOPH's Cash from Financing Activities over 5 years: stood at -$447000.0 in 2021, then decreased by 29.75% to -$580000.0 in 2022, then grew by 11.72% to -$512000.0 in 2023, then crashed by 128.12% to -$1.2 million in 2024, then surged by 67.04% to -$385000.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for SOPH at -$385000.0 in Q4 2025, -$2.0 million in Q3 2025, and $33.5 million in Q2 2025.